Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samar A Nasser

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Progress in Cardiovascular Diseases|December 10, 2019
Contemporary concepts in access to healthcare: Identification and elimination of disparities in care of minority patientsSamar A Nasser, Fortunato Fred Senatore
Current Hypertension Reports|May 2, 2003
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Major outomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diureticJohn M Flack, Samar A Nasser,
Current Hypertension Reports|April 12, 2018
Community Outreach to African-Americans: Implementations for Controlling HypertensionSamar A Nasser, Keith C Ferdinand
Current Hypertension Reports|March 11, 2015
Understanding the Importance of Race/Ethnicity in the Care of the Hypertensive PatientKeith C Ferdinand, Samar A Nasser
Vascular Health and Risk Management|January 14, 2012
Benefits of once-daily therapies in the treatment of hypertensionJohn M Flack, Samar A Nasser
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 21, 2013
A review of the efficacy and tolerability of combination amlodipine/valsartan in non-white patients with hypertensionKeith C Ferdinand, Samar A Nasser
Cardiology Clinics|April 17, 2017
Management of Essential HypertensionKeith C Ferdinand, Samar A Nasser
Cardiovascular Drugs and Therapy|June 13, 2015
PCSK9 Inhibition: Discovery, Current Evidence, and Potential Effects on LDL-C and Lp(a)Keith C Ferdinand, Samar A Nasser
Mayo Clinic Proceedings|May 6, 2017
Disparate Cardiovascular Disease Rates in African Americans: The Role of Stress Related to Self-Reported Racial DiscriminationKeith C Ferdinand, Samar A Nasser
Current Medical Research and Opinion|March 17, 2015
Racial/ethnic disparities in prevalence and care of patients with type 2 diabetes mellitusKeith C Ferdinand, Samar A Nasser
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Progress in Cardiovascular Diseases|December 10, 2019
Contemporary concepts in access to healthcare: Identification and elimination of disparities in care of minority patientsSamar A Nasser, Fortunato Fred Senatore
Current Hypertension Reports|May 2, 2003
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Major outomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diureticJohn M Flack, Samar A Nasser,
Current Hypertension Reports|April 12, 2018
Community Outreach to African-Americans: Implementations for Controlling HypertensionSamar A Nasser, Keith C Ferdinand
Current Hypertension Reports|March 11, 2015
Understanding the Importance of Race/Ethnicity in the Care of the Hypertensive PatientKeith C Ferdinand, Samar A Nasser
Vascular Health and Risk Management|January 14, 2012
Benefits of once-daily therapies in the treatment of hypertensionJohn M Flack, Samar A Nasser
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|June 21, 2013
A review of the efficacy and tolerability of combination amlodipine/valsartan in non-white patients with hypertensionKeith C Ferdinand, Samar A Nasser
Cardiology Clinics|April 17, 2017
Management of Essential HypertensionKeith C Ferdinand, Samar A Nasser
Cardiovascular Drugs and Therapy|June 13, 2015
PCSK9 Inhibition: Discovery, Current Evidence, and Potential Effects on LDL-C and Lp(a)Keith C Ferdinand, Samar A Nasser
Mayo Clinic Proceedings|May 6, 2017
Disparate Cardiovascular Disease Rates in African Americans: The Role of Stress Related to Self-Reported Racial DiscriminationKeith C Ferdinand, Samar A Nasser
Current Medical Research and Opinion|March 17, 2015
Racial/ethnic disparities in prevalence and care of patients with type 2 diabetes mellitusKeith C Ferdinand, Samar A Nasser
Pageof 4